| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
8,491 |
6,760 |
$779K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,597 |
1,203 |
$683K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,686 |
4,620 |
$481K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,536 |
2,032 |
$296K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,751 |
2,010 |
$242K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
842 |
636 |
$194K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,058 |
898 |
$193K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,560 |
1,143 |
$94K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
305 |
267 |
$73K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,074 |
913 |
$70K |
| 87631 |
|
576 |
525 |
$47K |
| 80053 |
Comprehensive metabolic panel |
5,651 |
4,494 |
$46K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,841 |
1,549 |
$32K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,081 |
4,723 |
$30K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
70 |
64 |
$19K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,259 |
1,120 |
$17K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
399 |
357 |
$14K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,843 |
1,299 |
$13K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
158 |
129 |
$12K |
| 70450 |
Computed tomography, head or brain; without contrast material |
57 |
51 |
$11K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,644 |
1,357 |
$11K |
| 87507 |
|
34 |
27 |
$10K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
136 |
41 |
$10K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
235 |
219 |
$7K |
| 81003 |
|
2,181 |
1,808 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
926 |
737 |
$7K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,876 |
1,585 |
$7K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
150 |
128 |
$7K |
| 84484 |
|
1,374 |
1,008 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
470 |
403 |
$7K |
| 71046 |
Radiologic examination, chest; 2 views |
296 |
252 |
$6K |
| 80061 |
Lipid panel |
578 |
533 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,447 |
1,096 |
$6K |
| 85027 |
|
1,346 |
1,055 |
$5K |
| 83605 |
|
939 |
760 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
8,579 |
6,437 |
$5K |
| 71045 |
Radiologic examination, chest; single view |
995 |
849 |
$5K |
| 86140 |
|
1,269 |
1,007 |
$4K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,457 |
1,173 |
$4K |
| 87081 |
|
472 |
399 |
$4K |
| 83690 |
|
856 |
710 |
$4K |
| G0378 |
Hospital observation service, per hour |
65 |
49 |
$3K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
14 |
12 |
$3K |
| 73564 |
|
37 |
27 |
$2K |
| 85610 |
|
729 |
617 |
$2K |
| 81001 |
|
986 |
857 |
$2K |
| 86141 |
|
267 |
220 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
267 |
239 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
13 |
13 |
$2K |
| 85379 |
|
376 |
339 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
61 |
57 |
$2K |
| 86803 |
|
101 |
90 |
$1K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
153 |
54 |
$1K |
| 99000 |
|
261 |
213 |
$950.29 |
| 85007 |
|
305 |
235 |
$872.03 |
| 73630 |
|
18 |
14 |
$850.39 |
| 83880 |
|
84 |
66 |
$849.35 |
| 80050 |
General health panel |
41 |
40 |
$848.64 |
| 81025 |
|
113 |
90 |
$779.59 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
32 |
29 |
$730.19 |
| 73610 |
|
13 |
13 |
$629.13 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15 |
12 |
$547.58 |
| 80305 |
|
49 |
40 |
$403.62 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
13 |
12 |
$331.28 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
12 |
$331.28 |
| 83735 |
|
66 |
44 |
$290.72 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
13 |
12 |
$272.82 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
30 |
28 |
$240.37 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,642 |
1,270 |
$197.78 |
| 82607 |
|
15 |
12 |
$184.96 |
| 82962 |
|
135 |
69 |
$160.67 |
| 87186 |
|
33 |
26 |
$141.88 |
| 83540 |
|
25 |
24 |
$123.16 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
52 |
45 |
$121.63 |
| 85652 |
|
58 |
54 |
$106.96 |
| 87077 |
|
13 |
12 |
$74.61 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
811 |
736 |
$54.49 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
928 |
652 |
$54.30 |
| 82150 |
|
16 |
13 |
$46.90 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
141 |
114 |
$39.95 |
| J7050 |
Infusion, normal saline solution, 250 cc |
773 |
389 |
$38.22 |
| J2704 |
Injection, propofol, 10 mg |
290 |
263 |
$31.94 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,623 |
1,306 |
$29.51 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
16 |
14 |
$10.87 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
556 |
496 |
$0.14 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
249 |
215 |
$0.08 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
35 |
29 |
$0.00 |
| 96376 |
|
13 |
12 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
46 |
39 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
104 |
95 |
$0.00 |
| A9270 |
Non-covered item or service |
38 |
29 |
$0.00 |
| 80320 |
|
15 |
12 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
305 |
221 |
$0.00 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
30 |
30 |
$0.00 |